China SXT Pharmaceuticals Inc (SXTC) — Cash Flow Reinvestment Rate
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting $25.28K (capex $25.28K ) from operating cash flow of $234.18K. Explore how much does China SXT Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China SXT Pharmaceuticals Inc Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for China SXT Pharmaceuticals Inc across 6 annual periods. Also explore how large is China SXT Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China SXT Pharmaceuticals Inc (2016–2022)
Year-by-year capital reinvestment analysis for China SXT Pharmaceuticals Inc. For live market cap and broader valuation context, see China SXT Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.41x | $109.40K | $268.29K | $62.49K | ▼ -93.5% |
| 2020 | 6.32x | $5.90 Million | $934.25K | $406.66K | ▲ +23.9% |
| 2019 | 5.10x | $1.22 Million | $239.19K | $610.09K | ▲ +346.5% |
| 2018 | 1.14x | $2.19 Million | $1.92 Million | $1.05 Million | ▼ -91.1% |
| 2017 | 12.89x | $3.78 Million | $293.04K | $186.31K | ▲ +2324.4% |
| 2016 | 0.53x | $96.99K | $182.47K | $96.99K | — |